Copertina

Synergistic effects of hypertension and diabetes on cardiovascular risk in elderly: Comparative longitudinal analysis of CHARLS and HRS

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Qiang Su, Wan‐Zhong Huang, Yuan Huang, Li‐Rong Mo, Jian‐He Lin, Zhong Qin
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Diabetes, Obesity and Metabolism
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Trajectories of body mass index and diabetes mellitus risk among elderly Chinese adults: A 10‐year longitudinal study
di: Yan Guo, et al.
Pubblicazione: (2025)

Explainable machine learning‐driven predictive modelling of incident cognitive impairment in individuals with early‐stage cardiovascular–kidney–metabolic syndrome: Insights from a longitudinal CHARLS cohort study
di: Shoupeng Duan, et al.
Pubblicazione: (2025)

Metformin lowers risk of hearing loss and mortality in type 2 diabetes
di: Chun‐Chih Huang, et al.
Pubblicazione: (2024)

Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus
di: Cheng Zu, et al.
Pubblicazione: (2024)

Impact of healthy lifestyles on the risk of metabolic dysfunction‐associated steatotic liver disease among adults with comorbid hypertension and diabetes: Novel insight from a largely middle‐aged and elderly cohort in South China
di: Jun‐Yan Xi, et al.
Pubblicazione: (2025)

The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle‐aged and elderly population: A nationwide prospective cohort study
di: Qiang He, et al.
Pubblicazione: (2024)

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes
di: Jonas A. Andersen, et al.
Pubblicazione: (2025)

Unexpected cardiovascular risks of glucagon‐like peptide‐1 receptor agonist and aspirin co‐administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study
di: Chia‐Ming Lin, et al.
Pubblicazione: (2025)

Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study
di: Jiaying Ni, et al.
Pubblicazione: (2025)

Cost‐effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi‐ethnic country in Asia
di: Hsuan‐Yu Su, et al.
Pubblicazione: (2025)

Personalizing cardiovascular risk: Coronary artery calcium scans to improve statin use in adults with type 2 diabetes can be cost‐effective in select individuals
di: Darren Lau, et al.
Pubblicazione: (2024)

Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID ‐19: Up to 40 months’ follow‐up
di: Shiv Mehrotra‐Varma, et al.
Pubblicazione: (2024)

Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria
di: Rosa C. Golomb, et al.
Pubblicazione: (2024)

Synergies between diabetes and hyperhomocysteinaemia: New insights to predict and prevent adverse cardiovascular effects
di: Xue Fan, et al.
Pubblicazione: (2024)

Comprehensive risk factor control and its biomarker‐mediated association with diabetic microvascular complications
di: Jing‐Wei Gao, et al.
Pubblicazione: (2025)

Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
di: Moscho Michalopoulou, et al.
Pubblicazione: (2024)

Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model
di: Marga A. G. Helmink, et al.
Pubblicazione: (2024)

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
di: Filipe A. Moura, et al.
Pubblicazione: (2024)

Cognitive reserve, genetic risk, and lifestyle in the incidence and progression of type 2 diabetes: A large community‐based longitudinal study
di: Shaojie Han, et al.
Pubblicazione: (2025)

Targeted metabolomics reveals novel biomarkers for gestational diabetes mellitus
di: Zhuangfei Xu, et al.
Pubblicazione: (2025)

Changes in adiposity indices over 10 years and risk of type 2 diabetes: The Whitehall II cohort study
di: Cunrong Huang, et al.
Pubblicazione: (2025)

Association of lifestyle with reduced stroke risk in 41 314 individuals with diabetes: Two prospective cohort studies in China
di: Jian Su, et al.
Pubblicazione: (2024)

Association of cumulative exposure to cholesterol, high‐density lipoprotein, and glucose index with the risk of cardiovascular disease and all‐cause mortality: A longitudinal cohort study
di: Ruobing Tian, et al.
Pubblicazione: (2025)

Sex‐specific associations between haemoglobin glycation index and the risk of cardiovascular and all‐cause mortality in individuals with pre‐diabetes and diabetes: A large prospective cohort study
di: Jingqi Yang, et al.
Pubblicazione: (2024)

Adherence to physician visits for diabetes care and cardiovascular disease risk: A retrospective cohort study using an administrative claims database
di: Akira Okada, et al.
Pubblicazione: (2025)

Nomogram‐based prediction of hypoglycemia risk in elderly community‐dwelling patients with type 2 diabetes: Development and validation in a multicentre real‐world cohort
di: Lingxue Chen, et al.
Pubblicazione: (2025)

Research advances in understanding crosstalk between organs and pancreatic β‐cell dysfunction
di: Peng Huang, et al.
Pubblicazione: (2024)

Longitudinal trajectories of fasting plasma glucose predicting cardiovascular disease risk in Chinese patients with type 2 diabetes under health management
di: Shijun Liu, et al.
Pubblicazione: (2025)

The causal relationship between plasma protein‐to‐protein ratios and type 2 diabetes and its complications: Proteomics mendelian randomization study
di: Yue‐Yang Zhang, et al.
Pubblicazione: (2024)

An internet‐based platform with a low‐calorie dietary intervention improves cardiometabolic risk factors in overweight and obese people in China: Half‐year follow‐up results of a randomized controlled trial
di: Yang Zhong, et al.
Pubblicazione: (2024)

Development and validation of 10‐year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning‐based methods
di: Weinan Dong, et al.
Pubblicazione: (2024)

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
di: Djordje S. Popovic, et al.
Pubblicazione: (2024)

Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes
di: Jiaqiang Zhang, et al.
Pubblicazione: (2025)

Clinical effectiveness and cost‐effectiveness of first‐line early combination of dipeptidyl peptidase 4 inhibitors and metformin in patients with type 2 diabetes in Taiwan: A modelling study
di: Thi Thuy Dung Nguyen, et al.
Pubblicazione: (2025)

Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials
di: Magdaline Zawadka, et al.
Pubblicazione: (2026)

Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide ( SEMA ‐elderly)
di: Vincenzo Fiore, et al.
Pubblicazione: (2025)

Oxidative stress, senescence and mRNA decay in peripheral blood mononuclear cells of women with gestational diabetes mellitus ‐link to increased cardiovascular disease risk
di: Tove Lekva, et al.
Pubblicazione: (2025)

Estimating the risk of cardiovascular outcomes and all‐cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data
di: Ruth L. Coleman, et al.
Pubblicazione: (2025)

Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double‐blind, randomised, placebo‐controlled cross‐over trial
di: Luxcia Kugathasan, et al.
Pubblicazione: (2026)

Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management
di: Mingyang Sun, et al.
Pubblicazione: (2024)